Yarmohammadi, H.; Ridouani, F.; Zhao, K.; Sotirchos, V.S.; Son, S.Y.; Geevarghese, R.; Marinelli, B.; Ghosn, M.; Erinjeri, J.P.; Boas, F.E.;
et al. Adjusted Tumor Enhancement on Dual-Phase Cone-Beam CT: Predictor of Response and Overall Survival in Patients with Liver Malignancies Treated with Hepatic Artery Embolization. Curr. Oncol. 2024, 31, 3030-3039.
https://doi.org/10.3390/curroncol31060231
AMA Style
Yarmohammadi H, Ridouani F, Zhao K, Sotirchos VS, Son SY, Geevarghese R, Marinelli B, Ghosn M, Erinjeri JP, Boas FE,
et al. Adjusted Tumor Enhancement on Dual-Phase Cone-Beam CT: Predictor of Response and Overall Survival in Patients with Liver Malignancies Treated with Hepatic Artery Embolization. Current Oncology. 2024; 31(6):3030-3039.
https://doi.org/10.3390/curroncol31060231
Chicago/Turabian Style
Yarmohammadi, Hooman, Fourat Ridouani, Ken Zhao, Vlasios S. Sotirchos, Sam Y. Son, Ruben Geevarghese, Brett Marinelli, Mario Ghosn, Joseph P. Erinjeri, Franz E. Boas,
and et al. 2024. "Adjusted Tumor Enhancement on Dual-Phase Cone-Beam CT: Predictor of Response and Overall Survival in Patients with Liver Malignancies Treated with Hepatic Artery Embolization" Current Oncology 31, no. 6: 3030-3039.
https://doi.org/10.3390/curroncol31060231
APA Style
Yarmohammadi, H., Ridouani, F., Zhao, K., Sotirchos, V. S., Son, S. Y., Geevarghese, R., Marinelli, B., Ghosn, M., Erinjeri, J. P., Boas, F. E., & Solomon, S. B.
(2024). Adjusted Tumor Enhancement on Dual-Phase Cone-Beam CT: Predictor of Response and Overall Survival in Patients with Liver Malignancies Treated with Hepatic Artery Embolization. Current Oncology, 31(6), 3030-3039.
https://doi.org/10.3390/curroncol31060231
